abstract |
The present invention is a compound represented by formula (I), an isomer, a racemate, a pharmaceutically acceptable salt, a crystalline hydrate, a solvate, or a mixture thereof. [Effect] The present invention relates to one kind of cyclic peptide compound, a process for producing the same, a pharmaceutical composition and use thereof. Specifically, the cyclic peptide compound according to the present invention has a structure represented by the formula (I). A compound represented by formula (I), an isomer, a racemate, a pharmaceutically acceptable salt, a crystal hydrate, a solvent, which has a preparation for preventing or treating histone deacetylase dysregulation The sum, or a mixture thereof, has use for the manufacture of a medicament for preventing or treating mammalian diseases associated with dysregulation of histone deacetylase. [Selection figure] None |